BBS-Bioactive Bone Substitutes Oyj (HE:BONEH) — Stock Price
BBS-Bioactive Bone Substitutes Oyj (HE:BONEH) is currently trading at €0.05 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.05 and €0.05. This page tracks BBS-Bioactive Bone Substitutes Oyj's live share price on the HE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BBS-Bioactive Bone Substitutes Oyj stock valuation.
BBS-Bioactive Bone Substitutes Oyj (BONEH) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BBS-Bioactive Bone Substitutes Oyj's daily closing share price and trading volume on the HE exchange over the past year, giving a clear view of recent price momentum and liquidity.
BBS-Bioactive Bone Substitutes Oyj Income Statement — Revenue, Profit & Earnings by Year
BBS-Bioactive Bone Substitutes Oyj's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Revenue | €0.00 | €0.00 | €0.00 | €0.00 | €105.69K |
| Cost of Revenue | €3.62K | €29.95K | €56.95K | €83.06K | €105.69K |
| Gross Profit | €-3.62K | €-29.95K | €-56.95K | €-83.06K | €-106.00K |
| Research & Development | — | — | — | — | — |
| SG&A | — | €1.31 Million | €1.20 Million | €794.82K | — |
| Total Operating Expenses | €3.36 Million | €2.92 Million | €2.51 Million | €2.56 Million | €1.43 Million |
| Operating Income | €-3.37 Million | €-2.95 Million | €-2.57 Million | €-2.65 Million | €-1.54 Million |
| EBITDA | €-3.15 Million | €-2.73 Million | €-2.34 Million | €-2.43 Million | €-1.31 Million |
| EBIT | €-3.37 Million | €-2.95 Million | €-2.57 Million | €-2.64 Million | €-1.54 Million |
| Interest Expense | €116.97K | €141.05K | €199.88K | €85.92K | €102.21K |
| Income Before Tax | €-3.48 Million | €-3.09 Million | €-2.77 Million | €-2.73 Million | €-1.64 Million |
| Income Tax Expense | €3.00 | €141.01K | €200.22K | €85.92K | €102.63K |
| Net Income | €-3.48 Million | €-3.09 Million | €-2.77 Million | €-2.73 Million | €-1.64 Million |
BBS-Bioactive Bone Substitutes Oyj Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BBS-Bioactive Bone Substitutes Oyj's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Assets | €10.61 Million | €10.69 Million | €10.51 Million | €12.69 Million | €9.83 Million |
| Total Current Assets | €2.02 Million | €1.92 Million | €1.57 Million | €3.65 Million | €656.51K |
| Cash & Equivalents | — | €1.52 Million | €1.24 Million | €3.44 Million | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | — | €396.61K | €332.64K | €210.49K | €140.88K |
| Inventory | — | €-400.42K | €-331.93 | €-209.53 | €-140.51 |
| Property, Plant & Equipment | — | €1.02 Million | €1.15 Million | €1.20 Million | €1.28 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €5.50 Million | €6.42 Million | €6.87 Million | €6.61 Million | €6.75 Million |
| Total Current Liabilities | €1.38 Million | €1.70 Million | €1.57 Million | €723.91K | €1.39 Million |
| Long-term Debt | €3.95 Million | €4.54 Million | €5.12 Million | €5.71 Million | €5.37 Million |
| Net Debt | €2.78 Million | €4.16 Million | €4.97 Million | €2.57 Million | €5.81 Million |
| Total Stockholder Equity | €5.11 Million | €4.27 Million | €3.63 Million | €6.09 Million | €3.08 Million |
| Retained Earnings | €-22.11 Million | €-18.63 Million | €-15.54 Million | €-12.77 Million | €-10.03 Million |
BBS-Bioactive Bone Substitutes Oyj Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BBS-Bioactive Bone Substitutes Oyj generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-2.92 Million | €-2.82 Million | €-2.52 Million | €-2.42 Million | €-1.44 Million |
| Capital Expenditures | €0.00 | €78.00K | €125.00K | €82.00K | €24.00K |
| Free Cash Flow | €-2.92 Million | €-2.89 Million | €-2.65 Million | €-2.50 Million | €-1.47 Million |
| Investing Cash Flow | — | €-78.00K | €-125.00K | €-82.00K | €-24.00K |
| Financing Cash Flow | €3.38 Million | €3.17 Million | €443.00K | €5.42 Million | €299.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €217.00K | €225.00K | €231.00K | €214.00K | €225.00K |
| Change in Cash | €454.00K | €281.00K | €-2.20 Million | €2.92 Million | €-1.17 Million |
BBS-Bioactive Bone Substitutes Oyj Earnings History — EPS Actual vs. Analyst Estimates
Track BBS-Bioactive Bone Substitutes Oyj's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 31, 2022 | -0.13 | — | — |
| Jun 30, 2022 | -0.21 | — | — |
| Dec 31, 2021 | -0.18 | — | — |
| Jun 30, 2021 | -0.19 | — | — |
| Dec 31, 2020 | -0.19 | — | — |
| Jun 30, 2020 | -0.27 | — | — |
| Mar 20, 2020 | -0.13 | — | — |